Les inscriptions sont ouvertes pour notre programme de 4 mois à temps plein, à Mila, conçu spécifiquement pour les fondateurs et fondatrices de la deep tech issus de parcours d'élite en STIM. Vous avez jusqu'au 21 novembre 2026 pour appliquer!
Offert par Mila et le Forum des politiques publiques, ce programme est conçu pour outiller les décideur·euse·s et les responsables des politiques publiques à naviguer efficacement à travers les opportunités et les risques liés à l'IA. La prochaine cohorte se tiendra en anglais les 5 et 6 novembre 2026 à Ottawa.
Le processus de demandes de supervision à Mila est maintenant ouvert! Vous pouvez appliquer dès maintenant à la maitrise de recherche ou Doctorat et joindre notre grande communauté de chercheur·euse·s à Mila pour l’automne 2027. Date limite : 1er décembre 2026
Nous utilisons des témoins pour analyser le trafic et l’utilisation de notre site web, afin de personnaliser votre expérience. Vous pouvez désactiver ces technologies à tout moment, mais cela peut restreindre certaines fonctionnalités du site. Consultez notre Politique de protection de la vie privée pour en savoir plus.
Paramètre des cookies
Vous pouvez activer et désactiver les types de cookies que vous souhaitez accepter. Cependant certains choix que vous ferez pourraient affecter les services proposés sur nos sites (ex : suggestions, annonces personnalisées, etc.).
Cookies essentiels
Ces cookies sont nécessaires au fonctionnement du site et ne peuvent être désactivés. (Toujours actif)
Cookies analyse
Acceptez-vous l'utilisation de cookies pour mesurer l'audience de nos sites ?
Lecteur Multimédia
Acceptez-vous l'utilisation de cookies pour afficher et vous permettre de regarder les contenus vidéo hébergés par nos partenaires (YouTube, etc.) ?
Abstract Accurately predicting cellular responses to drugs remains a challenge with the potential to reduce experimental screening costs and… (voir plus) accelerate drug discovery. Current computational approaches represent compounds through chemical structures, which carry little information regarding their activity within biological systems. We show that gene expression responses, measured in a reference cell line, can instead serve as transferable representations of chemical perturbations. The proposed framework, BioPert, uses biological representations with a small neural network to predict transcriptional delta responses in cell lines of different lineages. Across the Tahoe-100M and LINCS L1000 datasets, BioPert outperforms molecular fingerprints and embeddings learned from chemical structure, which provide limited improvements over random controls. BioPert’s prediction correlations reach 0.79 on Tahoe-100M, corresponding to an improvement of 0.34 over the next-best representation. On LINCS, performance varies with the experimental reproducibility of the test conditions, highlighting the impact of batch effects. Notably, BioPert considerably surpasses predictions obtained by copying the reference response, demonstrating that it captures context-dependent effects. Further analysis of a C32-cobimetinib case shows pathway-level accuracy of the predictions, including when the reference and target responses differ. These results open a new path for chemical perturbation prediction and could ultimately reduce the burden of phenotypic screening.
Metagenomic sequencing has uncovered billions of proteins from uncultured microorganisms, vastly expanding the known protein space. Yet most… (voir plus) remain functionally inaccessible because existing annotation methods depend on close homologs or accurate structure predictions. Here, we show that protein language models (pLMs) can unlock this diversity only when their training data are appropriately curated. We introduce Residue Embedding Diversity (RED), a metric for protein quality assessment orders of magnitude cheaper than likelihood, and a calibration task that measures model alignment with natural evolutionary distributions. We discover a fundamental trade-off between evolutionary calibration and structural modeling, establishing training data composition as a primary determinant of pLM behavior. Finally, we successfully retrieve diverse enzyme candidates from billions of metagenomic sequences and validate their expression in vivo .
Recent innovations in architecture, pre-training, and fine-tuning have led to the remarkable in-context learning and reasoning abilities of … (voir plus)large auto-regressive language models such as LLaMA and DeepSeek. In contrast, encoders like BERT and RoBERTa have not seen the same level of progress despite being foundational for many downstream NLP applications. To bridge this gap, we introduce NeoBERT, a next-generation encoder that redefines the capabilities of bidirectional models by integrating state-of-the-art advancements in architecture, modern data, and optimized pre-training methodologies. NeoBERT is designed for seamless adoption: it serves as a plug-and-play replacement for existing base models, relies on an optimal depth-to-width ratio, and leverages an extended context length of 4,096 tokens. Despite its compact 250M parameter footprint, it achieves state-of-the-art results on the massive MTEB benchmark, outperforming BERT large, RoBERTa large, NomicBERT, and ModernBERT under identical fine-tuning conditions. In addition, we rigorously evaluate the impact of each modification on GLUE and design a uniform fine-tuning and evaluation framework for MTEB. We release all code, data, checkpoints, and training scripts to accelerate research and real-world adoption.